Vidhya Rekha U, Prabhu MN, Bhuminathan. S
Vidhya Rekha U1, Prabhu MN2, Bhuminathan. S3
1Reader, Department of Public Health Dentistry, Sree Balaji Dental College and Hospital, Pallikaranai, Chennai - 600100, India.
2Assistant Professor in Periodontics, College of Dentistry, Department of Periodontics, Ajman University, Ajman, UAE.
3Department of Prosthodontics, Sree Balaji Dental College and Hospital, BIHER, Pallikaranai, Chennai-600100, India.
Volume - 15,
Issue - 7,
Year - 2022
Cancer is a one of the leading causes of death in the world, continue to be worldwide eradicator. Multi-drug resistance (MDR) is a major problem with the current treatment options. It is now widely believed that many herbal dietary products are available as chemoprotective agents against commonly occurring cancer types. Piperine is an alkaloid; exhibit a wide spectrum of biological and pharmacological activities like anti-pyretic, antimetastatic, antidepressant, antiapoptotic and antitumor activity. In this review, to focus effect of piperine on anticancer research related to their mechanism of action and its ability to regulate cancer related gene action like oncogenic and tumour supprosser gene in cycle and apoptosis as well as its therapeutic perspectives on oral cancer, online-literature were studied which includes books on phytochemistry and the electronic search (SciFinder, Pubmed, the Web of Science, Scopus, Google Scholar and etc). Piperine action on apoptosis pathway via caspases signalling has been studied in many researches, in which piperine disrupts cell proliferation and induces apoptosis. Piperine had the ability to cause cell cycle arrest in G2/M phase and to activate caspase-3 and caspase-9 cascades showed selective cytotoxicity and also through the downregulation of cyclin B1 and enhanced phosphorylation of cyclin-dependent kinase-1 (CDK1) and check point kinase 2 in cell cycle. It also inhibits the functions of P-glycoprotein (P-gp) and CYP3A4, which not only affects drug metabolism but also re-sensitizes multidrug resistant (MDR) cancer cells. Anti-proliferative and pro-apoptotic nature of Piperine extends its activity by stabilizing the G-quadruplex structure formed at c-myc promoter region and down regulating its expression in cancer cells. Since there is very less evidence on oral cancer piperine strength the prospective to treat oral cancer as its usefulness for the above said molecular mechanism associate with other cancer. This shows the postern to piperine against oral cancer research. Further impost of the anticancer potency of piperine on in vivo and clinical trials need to be studied for anticancer drug development in oral cancer treatment.
Cite this article:
Vidhya Rekha U, Prabhu MN, Bhuminathan. S. Review on Anticancer properties of Piperine in Oral cancer: Therapeutic Perspectives. Research Journal of Pharmacy and Technology. 2022; 15(7):3338-2. doi: 10.52711/0974-360X.2022.00558
Vidhya Rekha U, Prabhu MN, Bhuminathan. S. Review on Anticancer properties of Piperine in Oral cancer: Therapeutic Perspectives. Research Journal of Pharmacy and Technology. 2022; 15(7):3338-2. doi: 10.52711/0974-360X.2022.00558 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2022-15-7-80
1. J. Ferlay, M. Colombet, I. Soerjomataram, C. Mathers, D.M. Parkin, M. Pineros, A. Znaor, F. Bray, Estimating the global cancer incidence and mortality in 2018: Globocan Sources and Methods, Int. J. Cancer 144 (2019) 1941–1953.
2. Preetha Anand, Ajaikumar B. Kunnumakara, Chitra Sundaram, Kuzhuvelil B. Harikumar, Sheeja T. Tharakan, Oiki S. Lai, Bokyung Sung, Bharat B. Aggarwal, Cancer is a Preventable Disease that Requires Major Lifestyle Changes, Pharmaceutical Research, Vol. 25, No. 9, September 2008
3. S.B. Prabha, Mohini Rao, M. R. Ramesh Kumar. Evaluation of in vitro Antioxidant, Antibacterial and Anticancer activities of leaf extracts of Cleome rutidosperma. Research J. Pharm. and Tech. 2017; 10(8): 2492-2496. doi: 10.5958/0974-360X.2017.00440.1
4. Chandrasekar. R, Sivagami. B, M. Niranjan Babu. A Pharmacoeconomic Focus on Medicinal Plants with Anticancer Activity. Res. J. Pharmacognosy and Phytochem. 2018; 10(1): 91-100. doi: 10.5958/0975-4385.2018.00015.8
5. Szallasi. Piperine: researchers discover new flavor in an ancient spice,. Trends in Pharmacological Sciences, vol. 26, no. 9, pp. 437–439, 2005.
6. Yenduri Suvarna, S K. Abdul Rahaman. In Vitro – In Vivo Evaluation of Antiurolithiatic activity of piperine from Piper nigrum. Research J. Pharm. and Tech. 2020; 13(1):63-68. doi: 10.5958/0974-360X.2020.00011.6
7. K. Srinivasan, “Black pepper and its pungent principlepiperine:a review of diverse physiological effects,” Critical Reviews in Food Science and Nutrition, vol. 47, no. 8, pp. 735–748, 2007.
8. Bezerra DP, Castro FO, Alves APNN, Pessoa C, Moraes MO, Silveira ER, Lima MAS, Elmiro FJM, Costa-Lotufo LV (2006) In vivo growth-inhibition of Sarcoma 180 by piplartine and piperine, two alkaloid amides from Piper. J Med Biol Res 39:801–807
9. Parmar VS, Jain SC, Bisht KS, Jain R, Taneja P, Jha A, Tyagi OD, Prasad AK, Wengel J, Olsen CE, Boll PM (1997) Phytochemistry of the genus Piper. Phytochemistry 46:597–673.
10. Rutuja Sawant, Aloka Baghkar, Sanjukta Jagtap, Lina Harad, Anagha Chavan, Nilofar A. Khan, Rupali P. Yevale, Mohan K. Kale. A Review on - Herbs in Anticancer. Asian J. Res. Pharm. Sci. 2018; 8(4):179-184. doi: 10.5958/2231-5659.2018.00031.0
11. Mohammed Shakir Ghouse. An Overview on plant derived Anticancer Drugs. Res. J. Pharmacognosy and Phytochem. 2020; 12(4):235-244. doi: 10.5958/0975-4385.2020.00040.0
12. Mayur S. Jain, Mayur R. Bhurat, Sunil R Bavaskar. Melphalan flufenamide is an Anticancer medication used to treat multiple Myeloma: A Review. Asian Journal of Research in Pharmaceutical Sciences. 2021; 11(4):291-4. doi: 10.52711/2231-5659.2021.00045
13. Anita S. Kulkarni, Remeth J. Dias, Vishwajeet S. Ghorpade, Kailas K Mali. Freeze dried Multicomponent Inclusion Complexes of Piperine with Cyclodextrin and Hydrophilic Polymers: Physicochemical Characterization and In vivo Anti-inflammatory Activity. Research J. Pharm. and Tech. 2020; 13(10):4916-4924. doi: 10.5958/0974-360X.2020.00864.1
14. Arti Mohan, G. Sangeetha. Formulation and Evaluation of Immediate Release Film Coated Tablets of An Anticancer Drug (Dasatinib). Research J. Pharm. and Tech 2019; 12(2):729-734. doi: 10.5958/0974-360X.2019.00129.X
15. Loeb LA, Bielas JH, Beckman RA (2008). Cancers exhibit a mutator phenotype: clinical implications. Cancer Res 68: 3551-3557.
16. Rupa Bhattacharya, Prajakta Naitam. Green Anticancer Drugs – An Review. Res. J. Pharmacognosy and Phytochem. 2019; 11(4): 231-243. doi: 10.5958/0975-4385.2019.00040.2
17. Hunter T (1991) Cooperation between oncogenes. Cell, 64: 249-270.
18. Choisy-Rossi C, Yonish-Rouach E (1998) Apoptosis and the cell cycle: the p53 connection. Cell Death Differ, 5: 129-131.
19. Nandhini S, Radha R , Vadivu R. Docking of Hematoporphyrin on Various Anticancer Drugs Targeting Enzymes. Asian J. Pharm. Res. 2016; 6(3): 123-130. doi: 10.5958/2231-5691.2016.00019.8
20. Do MT, Kim HG, Choi JH, Khanal T, Park BH, Tran TP, et al. Antitumor efficacy of piperine in the treatment of human HER2‑overexpressing breast cancer cells. Food Chem 2013;141:2591‑9.
21. Hwang YP, Yun HJ, Kim HG, Han EH, Choi JH, Chung YC, et al. Suppression of phorbol‑12‑myristate‑13‑acetate‑induced tumor cell invasion by piperine via the inhibition of PKC alpha/ERK1/2‑dependent matrix metalloproteinase‑9 expression. Toxicol Lett 2011;203:9‑19.
22. Y. P. Hwang, H. J. Yun, H. G. Kim et al., “Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by piperine via the inhibition of PKCα/ERK1/2-dependent matrix metalloproteinase-9 expression,” Toxicology Letters, vol. 203, no. 1, pp. 9–19, 2011.
23. Yaffe PB, Doucette CD, Walsh M, Hoskin DW. Piperine impairs cell cycle progression and causes reactive oxygen species‑dependent apoptosis in rectal cancer cells. Exp Mol Pathol 2013;94:109‑14.
24. Ouyang DY, Zeng LH, Pan H, Xu LH, Wang Y, Liu KP, et al. Piperine inhibits the proliferation of human prostate cancer cells via induction of cell cycle arrest and autophagy. Food ChemToxicol 2013;60:424‑30.
25. C. R. Pradeep and G. Kuttan, “Piperine is a potent inhibitor of nuclear factor-κB (NF-κB), c-Fos, CREB, ATF- 2 and proinflammatory cytokine gene expression in B16F-10 melanoma cells,” International Immunopharmacology, vol. 4, no. 14, pp. 1795–1803, 2004.
26. Lin Y, Xu J, Liao H, Li L, and Pan L: Piperine induces apoptosis of lung cancer A549 cells via p53- dependent mitochondrial signaling pathway. TumorBiol 35, 3305–3310, 2014.
27. Czabotar, P. E., Lessene, G., Strasser, A., and Adams, J. M. (2014). Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat. Rev. Mol. Cell Biol. 15, 49–63.
28. Looi, C. Y., Arya, A., Cheah, F. K., Muharram, B., Leong K, H., Mohamad, K., et al. (2013). Induction of apoptosis in human breast cancer cells via caspase pathway by vernodalin isolated from Centratherumanthelminticum (L). seeds. PLoS One 8, e56643.
29. Wu, H., Che, X., Zheng, Q., Wu, A., Pan, K., Shao, A., et al. (2014). Caspases: a molecular switch node in the crosstalk between autophagy and apoptosis. Int. J. Biol. Sci. 10, 1072–1083.
30. Abhilash Samykutty, Aditya Vittal Shetty, Gajalakshmi Dakshinamoorthy, Mary Margaret Bartik, Gary Leon Johnson, Brian Webb, Guoxing Zheng, Aoshuang Chen, Ramaswamy
31. Gnanasekar M, Thirugnanam S, Zheng G, Chen A, Ramaswamy K (2009) Gene silencing of translationally controlled tumor protein (TCTP) by siRNA inhibits cell growth and induces apoptosis of human prostate cancer cells. Int J Oncol 34:1241–6.
32. Han, S.-Z.; Liu, H.-X.; Yang, L.-Q.; Cui, L.; Xu, Y. Piperine (PP) enhanced mitomycin-C (MMC) therapy of human cervical cancer through suppressing Bcl-2 signaling pathway via inactivating STAT3/NF-B. Biomed. Pharmacother. 2017, 96, 1403–1410.
33. Si, L.; Yang, R.; Lin, R.; Yang, S. Piperine functions as a tumor suppressor for human ovarian tumor growth via activation of JNK/p38 MAPK-mediated intrinsic apoptotic pathway. Biosci.Rep. 2018, 38, BSR20180503.
34. Do, M.T.; Kim, H.G.; Choi, J.H.; Khanal, T.; Park, B.H.; Tran, T.P.; Jeong, T.C.; Jeong, H.G. Antitumor efficacy of piperine in the treatment of human HER2-overexpressing breast cancer cells. Food Chem. 2013, 141, 2591–2599.
35. Rabbits, T. H. (1994) Nature, 72, 143-149.
36. Weinberg, R. A. (1995) Ann. N. Y. Acad. Sci., 758, 331-338.
37. Zhou, Y., Ma, B. G., & Zhang, H. Y. (2007). Human oncogene tissue-specific expression level significantly correlates with sequence compositional features. FEBS Letters, 581, 4361–4365.
38. Todd, R., and Wong, D. T. (1999). Oncogenes. Anticancer Research, 19(6A), 4729–4746.
39. Mitsushita, J., David Lambeth, J., and Kamata, T. (2004). Thesuperoxide-generating oxidase Nox1 Is functionally required for Ras oncogene transformation. Cancer Research, 64, 3580–3585.
40. Fan Y, Mao R, Yang J. NF‑κB and STAT3 signaling pathways collaboratively link inflammation to cancer. Protein Cell 2013;4:176‑85.
41. C. R. Pradeep and G. Kuttan, “Piperine is a potent inhibitor of nuclear factor-κB (NF-κB), c-Fos, CREB, ATF- 2 and proinflammatory cytokine gene expression in B16F-10 melanoma cells,” International Immunopharmacology, vol. 4, no. 14, pp. 1795–1803, 2004.
42. Y. P. Hwang, H. J. Yun, H. G. Kim et al., “Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by piperine via the inhibition of PKCα/ERK1/2- dependent matrix metalloproteinase-9 expression,” Toxicology Letters, vol. 203, no. 1, pp. 9–19, 2011.
43. R. K. Bhardwaj, H. Glaeser, L. Becquemont, U. Klotz, S. K. Gupta, and M. F. Fromm, “Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4,”Journal of Pharmacology and Experimental Therapeutics, vol. 302, no. 2, pp. 645–650, 2002.
44. S. Li, Y. Lei, Y. Jia, N. Li, M. Wink, and Y. Ma, “Piperine, a piperidine alkaloid from Piper nigrum re-sensitizes Pgp, MRP1 and BCRP dependent multidrug resistant cancer cells,” Phytomedicine, vol. 19, no. 1, pp. 83–87, 2011.
45. Selvendiran, K., Prince Vijeya Singh, J., and Sakthisekaran, D. (2006). In vivo effect of piperine on serum and tissue glycoprotein levels in benzo (a) pyrene induced lung carcinogenesis in Swiss albino mice. Pulm. Pharmacol. Ther. 19, 107–111.
46. ArpitaTawani, Ayeman Amanullah, Amit Mishra and Amit Kumar, Evidences for Piperine inhibiting cancer by targeting human G-quadruplex DNA sequences, Scientific Reports, 6:39239, 2016
47. Meeran, S. M., and Katiyar, S. K. (2008). Cell cycle control as a basis for cancer chemoprevention through dietary agents. Front. Biosci. 13, 2191–2202.
48. Li-hua LAI, Qi-hong FU, Yang LIU, Kai JIANG, Qing-ming GUO, Qing-yun CHEN, Bin YAN, Qing- qing WANG, Jian-gen SHEN, Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer model, Acta Pharmacologica Sinica (2012) 33: 523–530
49. Zhang, J., Zhu, X., Li, H., Li, B., Sun, L., Xie, T., et al. (2015). Piperine inhibits proliferation of human osteosarcoma cells viaG2/Mphase arrest and metastasis by suppressing MMP-2/-9 expression. Int. Immunopharmacol. 24, 50–58.
50. Choi S, Myers JN. Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res 2008; 87: 14-32.
51. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. Journal of oral pathology andmedicine: official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 2007; 36(10):575–580.
52. Hamakawa H, Nakashiro K, Sumida T, et al. Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer. Head Neck 2008; 30: 800-9.
53. Siddiqui, S., Ahamad, M. S., Jafri, A., Afzal, M., and Arshad, M. (2017). Piperine triggers apoptosis of human oral squamous carcinoma through cell cycle arrest and mitochondrial oxidative stress. Nutr. Cancer 69, 791–799.